Stem cell study identifies early issues in Rett syndrome

feimage medium x

Neural stem cells from people with Rett syndrome show early signs of dysfunction, according to unpublished research presented at the 2012 Society for Neuroscience annual meeting in New Orleans. The results come from a comprehensive analysis of protein expression in neural progenitor cells, which mark the developmental stage between stem cells and neurons.

“What we’re trying to do is see if we can find the earliest molecular changes in patient-derived stem cells,” says senior investigator Anirvan Ghosh, professor of neurobiology at the University of California, San Diego, and head of discovery for the central nervous system at Swiss drugmaker Roche.

View the original article here: Stem cell study identifies early issues in Rett syndrome —

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image Jun 3, 2026, 03_14_43 PM
Viewpoint: How Earthjustice became the poster child for the abuse of special interest activist funding
ChatGPT Image Jun 3, 2026, 03_54_37 PM
Viewpoint: “Turn on, tune in, drop out”—Kennedy embraces the Timothy Leary psychedelic revolution
Screenshot-2026-06-05-at-2.12.30-PM
Some plants can poison you. So how did humans figure out what is safe to eat?
ChatGPT-Image-Jun-11-2026-01_15_03-PM
Selective Pressure, Selective Silence
Screenshot 2026-05-26 at 10.15
Viewpoint: Double standard—Why does the wellness industry get a free pass while Big Healthcare is treated as morally suspect?
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT Image May 28, 2026, 08_16_38 PM
Viewpoint: Why the EPA mismeasures cancer risk of chemicals and what should be done to fix it
ChatGPT Image Jun 1, 2026, 11_39_17 AM
Viewpoint: When food myths go viral, farmers pay the price
ChatGPT Image May 26, 2026, 08_42_17 AM (1)
Viewpoint: Greenpeace and poison: How environmental advocacy groups rely on compliant (and often ignorant) journalists to spread disinformation and spark litigation
Screenshot-2026-06-03-at-1.24.46-PM
Challenging anti-GMO disinformation: Why genetically-tweaked crops offer bushels of benefits

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.